🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

An honor to be co-chairs with Marie Carlo for the Kidney Cancer think tank. Really great discussion with people who truly care about improving the field. Stay tuned for what was discussed!

Join us in thanking the #IKCSNA24 Scientific Planning Committee for their extraordinary work to bring you this program! 👏 Stephanie Berg #JodiMaranchie #ManojBupathi Marie Carlo #DanGeynisman Phillip Pierorazio Sarah P. Psutka MD MS Qing Zhang Yousef Zakharia

Never in a million years did I think I would be speaking in front of brilliant minds sharing my patient perspective. An open and welcoming environment to hear theses stories is 🔑 to patients mental AND physical health. #IKCSNA24 Thank you Kidney Cancer 🧡🧡

Congratulations to David Braun Yale School of Medicine Yale Cancer Center for receiving the KCA's Christopher G. Wood Rising Star Award! #IKCSNA24

Thanks to the #IKCSNA24 planning committee!! Wonderful scientific & career programming. Kidney Cancer

Thanks to #IKCSNA24 for prioritizing patient voices! Kidney Cancer “Patient-Centered Outcomes in Kidney Cancer Research” - Ask patients for their preferred appointment times - Find out what topics they want to discuss with their oncologist - Focus on new metrics to capture

Congratulations to Dan George for receiving the KCA's Nicholas J. Vogelzang Humanitarian Award! #IKCSNA24

Thank you for joining us at #IKCSNA24 and making this milestone 25-year anniversary special! Please save the dates for our upcoming meetings! ⭐ 2025 IKCS: Europe - Amsterdam, May 1-3 ⭐ 2025 IKCS: North Am - Denver, CO, Nov 13-15 See you again soon! kidneycancer.org/ikcs/

An honest piece worth reading on the value in building connections to create a network👇. True in science, & also life in general.

#kidneycancer Patients want to be cured. They will accept treatments that increase survival - but they want cure. Thanks David Braun for continuing to repeat this mantra and for your efforts to make it a reality. shorturl.at/OIVjE

Treatment free survival is becoming an important endpoint when looking at different #mRCC treatments. VEGF alone had shortest TFS. Something to be said about treatment breaks. Thx to #mehulgupta and #meredithregan IMDC Rana McKay, MD, FASCO Tom Powles Toni Choueiri, MD European Urology Oncology

Burden of mRCC – Insights from KCCure survey 🛑 36% visited the ER, 23% hospitalized, 44% spend hours daily thinking about cancer 💊 1 in 3 worried about taking too many meds 🧬 More research needed to improve care & QoL! KCCure Dena Battle ASCO Yüksel Ürün #GU25

Great Poster by our friends at KCCure at #GU25 Spoke to First Author Dena Blattle Dena Battle who tells us more: Disease Burden in mRCC #kidneycancer pts spend HOURS⏳ thinking about #cancer. In last 9⃣0⃣ days, 36% have gone to ER. >1/3 of patients say that cancer

Exploring the burden of cancer in metastatic renal cell carcinoma (mRCC) 📊🧬 This study sheds light on the impact of mRCC on patients & healthcare systems. Don’t miss these key insights ASCO #GU25! Dena Battle KCCure

Clear cell RCC is heterogeneous. UTSW Simmons Cancer Center’s Tian Zhang, MD, MHS presents the new frontier and dares us to imagine patients unique disease treated uniquely. #GU25 #kidneycancer #diseaseburdenzero

70% of health-related internet searches are zero-click - which means pts are relying on snippets and AI overviews for information. When you see something like this that is outdated, misleading, or both - click on the feedback button. It's a small way you can help improve

So proud of Michael Staehler for this well deserved honor. Your relentless commitment to improving patient care inspires me every day. 🧡

Amsterdam • Keukenhof tulips, windmills, canals, and best of all, friends. Nothing better than getting to see great friends all together overseas. Missed being with everyone #IKCSEU25 but enjoyed dinner Tian Zhang, MD, MHS Dena Battle Michael Staehler

#ScientificTourDeForce and a brilliant demonstration of how much we can learn from outlier events and rare disease. #RMC The matrix of factors that impact immune function are vast, but not impenetrable, and offers avenues for immune based prevention. #WorthTheRead

📣 Live at #ASCO25: Learn from real-world #RCC cases with Sumanta K. Pal, MD, FASCO, Dr. McDermott & Tian Zhang, MD, MHS  ✅ IO-based regimens  ✅ Sequencing therapies  ✅ Shared decision-making  🗓️ May 31 | 7:00 PM CDT  🔗 bit.ly/RCC-T